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KEYWORDS	
	 Two	series	of	p‐alkyl‐	and	p‐alkoxy‐substituted	curcuminoids	were	synthesized.	The	validity
of	the	proposed	structures	was	checked	on	the	basis	of	their	high	resolution	mass	spectra	as
well	as	NMR,	 IR	and	electronic	spectra.	The	spectra	were	essentially	 similar	 for	both	series.
NMR,	IR	and	electronic	spectra	showed	that	the	compounds	exist	mainly	or	exclusively	as	the
enolic	tautomer	in	their	solutions.	Theoretical	study	for	the	electronic	spectra	was	conducted
to	 account	 for	 the	 origins	 of	 the	 electronic	 transitions	 that	 are	 responsible	 for	 the	 UV‐VIS
bands.	 The	 theoretical	 calculations	 were	 done	 at	 the	 B3LYP/6‐31G(d)	 level	 of	 theory	 and
predicted	that	the	similarity	of	the	electronic	spectra	is	may	be	due	to	the	close	resemblance
of	their	molecular	orbitals.	
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1.	Introduction	
	
Turmeric	 has	 been	 used	 in	 traditional	 medicine	 for	 the	
treatment	of	jaundice	and	other	liver	ailments,	ulcers,	parasitic	
infections,	 various	 skin	 diseases,	 sprains,	 inflammation	 of	 the	
joints,	cold	and	flu	symptoms.	It	is	also	used	for	preserving	food	
as	 antimicrobial	 [1].	 Curcumin,	 commonly	 called	 diferuloyl	
methane,	is	one	of	the	minor	constituents	of	turmeric	which	in	
addition	 to	 other	 analogs	 namely	 demethoxycurcumin	 (DMC)	
and	 bis‐demethoxycurcumin	 (BDMC)	 is	 responsible	 for	 the	
medicinal	activity	of	turmeric.	
Curcumin	is	a	hydrophobic	polyphenol	a	bi‐α,β‐unsaturated	
β‐diketone	structure	that	exhibits	keto‐enol	tautomerism.	It	is	a	
member	of	the	linear	diarylheptanoid	class	of	natural	products	
in	which	two	oxy‐substituted	aryl	moieties	are	linked	together	
through	a	seven‐carbon	chain	[2].	Its	crystal	structure	was	the	
subject	of	several	papers	which	are	agreed	that	the	enol‐form	is	
the	 major	 tautomer	 of	 curcumin	 [3‐5].	 This	 picture	 was	 also	
supported	by	both	spectral	and	theoretical	studies	[6‐10].		
One	 of	 the	 most	 important	 aspects	 of	 curcumin	 is	 its	
effectiveness	 against	 various	 types	 of	 cancer	 with	 both	
chemopreventive	and	chemotherapeutic	properties.	Properties	
exhibited	 by	 this	 compound	 include	 anti‐inflamatory,	 anti‐
oxidant,	 antiviral,	 cutaneous	 wound	 healing	 hypocholest‐
rolemic	 effects	 in	 adiabatic	 patients,	 anti‐angiogenic,	 and	
stimulatory	response	to	stress‐induced	biological	activity	[10].	
The	 most	 important	 feature	 of	 curcumin	 is	 its	 lack	 of	
toxicity.	 Unlike	 most	 chemotherapeutic	 agents,	 curcumin	 has	
been	shown	in	various	animal	models	and	human	studies	to	be	
extremely	safe	even	at	very	high	doses	with	little	to	no	toxicity	
(no	dose‐limiting	 toxicity	at	doses	up	 to	10	g/day	 in	humans)	
[11‐13].	These	properties	make	curcumin	a	valuable	compound	
for	drug	development.		
Despite	 these	 distinctive	 and	 unique	 properties	 its	
potential	usage	 is	 limited	due	 to	poor	bioavailability	and	poor	
selectivity	 that	have	been	highlighted	as	major	problems;	 and	
consequently	 search	 for	 a	 ‘‘super	 curcumin’’	 without	 these	
problems	 and	 with	 efficacy	 equal	 to	 or	 better	 than	 that	 of	
curcumin	 is	 ongoing.	 Two	 strategies	 used	 in	 the	 search	 for	
alternative	 curcumin,	 namely	 (1)	 synthetic	 analogs	 or	
derivatives	and	(2)	formulations.	The	first	is	the	most	explored	
and	numerous	synthetic	curcumin	analogs	with	a	wide	range	of	
applications	were	described	in	literature	[14‐18].		
To	our	knowledge	 the	 synthesis	of	 curcumin	analogs	with	
alkyl	 and	 alkoxy	 chain	 substituents	 (other	 than	 methyl‐,	
methoxy‐	 and	 ethoxy‐	 groups)	 at	 the	 flanking	 aromatic	 rings	
are	not	yet	undertaken.	It	could	be	assumed	that	long	alkyl‐	or	
alkyloxy‐	 substituents	 may	 increases	 the	 values	 of	
hydrophobicity	 (log	 Pow)	 for	 the	 derivatives	 leading	 to	 make	
them	more	 available	 in	 the	 lipid	 tissues	 at	which	 curcumin	 is	
known	to	work	as	an	anti‐oxidant.	
	
2.	Experimental	
	
2.1.	Instrumentation	
	
Infrared	 spectra	 are	 recorded	 on	 Perkin‐Elmer	 Spectrum	
100	 FTIR	 spectrometer,	 as	 ATR‐Infra	 red	 spectra.	 The	
electronic	spectra	are	measured	at	room	temperature	with	T+	
80	PG	 Instrument	UV/Vis	spectrophotometer	 in	ethanol	using	
quartz	cells	of	1	cm	path	length.	Mass	spectra	are	obtained	on	a	
HR	 Mass	 type	 Waters	 Synapt	 G2	 MS	 by	 using	 Electrospray	
method.	 NMR	 spectra	 were	 recorded	 with	 Varian	 500	 (500	
MHz)	 and	 Varian	 200	 (200	 MHz)	 Spectrometer	 with	
tetramethyl	 silane	 (TMS)	 as	 an	 internal	 standard,	 	 scale	 in	
ppm,	coupling	constant	in	Hz.		
Al‐Salem	et	al.	/	European	Journal	of	Chemistry	4	(1)	(2013)	70‐73	 71	
 
	
	
	
	
	 Compound	 R	 	
	
1	
2	
3	
4	
5	
6	
7	
‐C3H7	
‐C5H11	
‐C6H13	
‐C8H17	
‐OC3H7	
‐OC7H15	
‐OC8H17	
	
	
Scheme	1	
	
	
2.2.	Theoretical	calculations	
	
The	quantum	chemical	 calculations	were	performed	using	
the	 Firefly	 QC	 package	 [19]	 which	 is	 partially	 based	 on	 the	
GAMESS	 (US)	 source	 code	 [20].	 Geometrical	 optimizations	
were	 carried	 out	 using	 Density	 Functional	 Theory	 (DFT)	
method	at	B3LYP/6‐31G(d)	level	of	theory.	
	
2.3.	Synthesis	
	
Acetylacetone	 2.5	 g	 (0.023	 mol)	 and	 boric	 oxide	 1.2	 g	
(0.017	mol)	were	stirred	for	1	hour.	The	appropriate	aldehyde	
(0.046	 mol)	 was	 dissolved	 in	 dry	 dimethylacetamide	 (DMA)	
(50	mL),	heated	in	water	bath	at	80	oC,	and	tri	methyl	borate	5	
g	(0.046	mol)	were	added	to	the	complex.	The	reaction	mixture	
was	 stirred	 for	 5	 min.	 followed	 by	 a	 dropwise	 addition	 of	 a	
solution	 of	 n‐butylamine	 0.737	 g	 (0.01	 mol)	 in	 DMA	 over	 a	
period	of	1	hour.	The	mixture	was	stirred	 for	 further	3	hours.	
The	solution	was	set	aside	overnight.	Acetic	acid	(5	N,	70	mL)	
at	80	oC	was	then	added,	and	the	mixture	stirred	for	1	hour.	The	
mixture	 cooled	 and	 the	 solid	 product	 was	 collected	 by	
filtration,	and	then	washed	by	hot	water	twice	time,	dried	then	
recrystallized	from	the	appropriate	solvent	(Scheme	1).	
	(1E,6E)‐1,7‐bis(4‐propylphenyl)hepta‐1,6‐diene‐3,5‐dione	
(1):	 Color:	 Yellow	 needles,	 recrystallized	 from	 ethanol.	 Yield:	
56%.	M.p.:	139‐141	oC.	1H	NMR	(200	MHz	,	CDCl3,	δ	ppm):	0.95	
(6H,	t,	J	=	7.8	Hz,	CH3),	1.65	(4H,	m,	J	=	7.8	Hz,	CH2),	2.61	(4H,	t,	J	
=	7.8	Hz,	CH2),	5.82	(2H,	s,	vinylic	H	),	6.59	(2H,	d,	J	=	16.2	Hz,	
CH=C),	7.20	(4H,	d,	J	=	7.8	Hz,	Ar‐H),	7.47	(	4H,	d,	J	=	8.4	Hz,	Ar‐
H),	7.64	(2H,	d,	J	=	16.2	Hz,	CH=C).	13C	NMR	(75	MHz,	CDCl3,	δ	
ppm):	13.7,	24.3,	37.3,	101.5,	123.1,	128.1,	129.0,	132.5,	140.5,	
145.3,	183.3.	 IR	(ATR,	ν,	cm‐1):	3264,	2956,	2869,	1624,	1568,	
1463,	1417,	1324,	970,	816,	764.	MS	(70	eV,	m/z):	360.2	 (M),	
324.2,	 317.2,	 299.1,	 254.1,	 241.1,	 213.1,	 197.1,	 173.1,	 157.1,	
133.1,	115.1,	91.0,	69.1.	
(1E,6E)‐1,7‐bis(4‐pentylphenyl)hepta‐1,6‐diene‐3,5‐dione	
(2):	 Color:	 Yellow	 needles,	 recrystallized	 from	 ethanol.	 Yield:	
50%.	M.p:	122‐124	oC.	1H	NMR	(200	MHz,	CDCl3,	δ	ppm):	0.87	
(6H,	t,	J	=	6.6	Hz,	CH3),	1.32	(8H,	m,	CH2)	1.56	(4H,	m,	CH2),	2.62	
(4H,	t,	J	=	8	Hz,	CH2),	5.82	(2H,	s,	vinylic	H),	6.59	(2H,	d,	J	=	15.8	
Hz,	CH=C),	7.20	(4H,	d,	J	=	8	Hz,	Ar‐H),	7.48	(4H,	d,	J	=	8	Hz,	Ar‐
H),	 7.64	 (2H,	 d,	 J	=	16	Hz,	 CH=C).	 13C	NMR	 (75	MHz,	 CDCl3,	 δ	
ppm):	 13.9,	 22.5,	 30.9,	 31.4,	 35.8,	 101.5,	 123.1,	 128.1,	 129.0,	
132.4,	140.5,	145.6,	183.3.	IR	(ATR,	ν,	cm‐1):	3250,	2953,	2922,	
1626,	1567,	1454,	1417,	1275,	1139,	1018,	972,	874,	812,	764.	
MS	 (70	eV,	m/z):	416.3	 (M),	398.3,	368.3,	345.2,	327.2,	304.1,	
285.1,	257.1,	201.1,	185.1,	161.1,	131.0,	115.0,	95.4,	69.1.		
(1E,6E)‐1,7‐bis(4‐hexylphenyl)hepta‐1,6‐diene‐3,5‐dione	 (3):	
Color:	Yellow	needles,	recrystallized	from	ethanol.	Yield:	52%.	
M.p:	118‐120	oC.	1H	NMR	(200	MHz,	CDCl3,	δ	ppm):	0.88	(6H,	t,		
J	=	6.6	Hz,	CH3),	1.30	(8H,	m,	CH2),	1.57	(8H,	m,	CH2),	2.62	(4H,	t,	
J	=	7.8	Hz,	CH2),	5.82	(2H,	s,	vinylic	H),	6.59	(2H,	d,	J	=	15.8	Hz,	
CH=C),	7.20	(4H,	d,	J	=	8	Hz	,	Ar‐H	),7.48	(4H,	d,	J	=	8.4	Hz,	Ar‐H),	
7.64	(2H,	d,	J=	16	Hz,	CH=C).	13C	NMR	(75	MHz,	CDCl3,	δ	ppm):	
14.0,	 22.5,	 28.9,	 31.2,	 31.6,	 35.9,	 101.5,	 123.1,	 128.1,	 129.0,	
132.4,	140.5,	145.6,	183.3.	IR	(ATR,	ν,	cm‐1):	3244,	2921,	2852,	
1623,	 1604,	 1565,	 1455,	 1417,	 1275,	 1181,	 1139,	 1017,	 973,	
873,	824,	764.	MS	(70	eV,	m/z):	444.3	(M),	416.3,	398.3,	359.2,	
341.2,	 320.2,	 289.1,	 255.1,	 236.2,	 215.1,	 197.1,	 175.1,	 157.0,	
131.0,	109.1,	91.1.	
	(1E,6E)‐1,7‐bis(4‐octylphenyl)hepta‐1,6‐diene‐3,5‐dione	 (4):	
Color:	Yellow	needles,	recrystallized	from	ethanol.	Yield:	47%.	
M.p:	130‐131	oC.	1H	NMR	(200	MHz,	CDCl3,	δ	ppm):	0.87	(6H,	t,		
J	=	7	Hz,	CH3),	1.28	(8H,	m,	CH2),	1.57	(16H,	m,	CH2),	2.62	(4H,	t,	
J	=	7.6	Hz,	CH2),	5.82	(2H,	s,	vinylic	H),	6.59	(2H,	d,	J	=	16.2	Hz,	
CH=C),	7.20	(4H,	d,	J	=	8	Hz,	Ar‐H),	7.47	(4H,	d,	J	=	8.4	Hz,	Ar‐H),	
7.64	 (2H,	 d,	 J	 =	 15.8	 Hz,	 CH=C).	 13C	 NMR	 (75	 MHz,	 CDCl3,	 δ	
ppm):	14.0,	22.6,	29.2,	29.3,	29.4,	31.2,	31.8,	35.9,	101.5,	123.1,	
128.1,	129.0,	132.4,	140.5,	145.6,	183.0.	IR	(ATR,	ν,	cm‐1):	3244,	
2955,	2918,	2848,	1623,	1604,	1567,	1468,	1417,	1369,	1275,	
1139,	 1017,	 973,	 873,	 819,	 749,	 716.	MS	 (70	 eV,	m/z):	 500.4	
(M),	 472.4,	 444.4,	 404.4,	 369.4,	 341.2,	 317.2,	 283.1,	 256.1,	
215.1,	185.1,	157.1,	131.0,	105.1,	80.0,	57.1.		
(1E,6E)‐1,7‐bis(4‐propyloxyphenyl)hepta‐1,6‐diene‐3,5‐dione	
(5):	 Color:	 Orange	 needles,	 recrystallized	 from	 ethanol.	 Yield:	
50	%.	M.p:	142‐144	oC.	1H	NMR	(200	MHz,	CDCl3,	δ	ppm):	1.04	
(6H,	 t,	 J	=	7.2	Hz,	 CH3),	 1.82	 (4H,	 sixtet,	 J	=	7.2	Hz,	 CH2),	 3.96	
(4H,	 t,	 J	=	6.6	Hz,	CH2),	5.82	(2H,	s,	vinylic	H),	6.49	(2H,	d,	 J	=	
15.6	Hz,	CH=C),	6.90	(4H,	d,	J	=	8.4	Hz,	Ar‐H),	7.49	(4H,	d,	J	=	9	
Hz,	 Ar‐H),	 7.61	 (2H,	 d,	 J	=	15.6	Hz,	 CH=C).	 13C	NMR	 (75	MHz,	
CDCl3,	 δ	 ppm):	 25.9,	 31.7,	 68.1,	 114.6,	 127.5,	 128.7,	 165.1,	
174.3,	183.1.	 IR	 (ATR,	ν,	cm‐1):	3310,	2957,	2878,	1620,	1600,	
1573,	1495,	1421,	961,	836,	750.	MS	(70	eV,	m/z):	392.2	 (M),	
374.2,	 353.4,	 331.2,	 313.3,	 296.1,	 279.1,	 256.1,	 229.1,	 213.1,	
189.1,	147.0,	131.1,	107.1,	83.1,	69.1.	
(1E,6E)‐1,7‐bis(4‐heptyloxyphenyl)hepta‐1,6‐diene‐3,5‐dione	
(6):	 Color:	 Orange	 needles,	 recrystallized	 from	 ethanol.	 Yield:	
48	%.	M.p:	118‐120	oC.	1H	NMR	(200	MHz,	CDCl3,	δ	ppm):	0.89	
(6H,	 t,	 J	=	6.6	Hz,	CH3),	1.42	 (12H,	m,	CH2),	1.79	 (8H,	m,	CH2),	
3.98	(4H,	t,	J	=	6.6	Hz,	CH2),	5.77	(2H,	s,	vinylic	H),	6.49	(2H,	d,	J	
=	15.8	Hz,	CH=C),	6.90	(4H,	d,	J	=	8.8	Hz,	Ar‐H	),	7.49	(4H,	d,	J	=	
8.8	Hz,	Ar‐H),	7.61	(2H,	d,	J	=	16.0	Hz,	CH=C).	13C	NMR	(75	MHz,	
CDCl3,	 δ	 ppm):	 14.0,	 22.5,	 25.3,	 29.0,	 31.7,	 68.1,	 141.8,	 127.5,	
129.7,	165.1,	174.3,	183.3.	IR	(ATR,	ν,	cm‐1):	3246,	3915,	2825,	
1620,	1600,	1573,	1510,	1469,	1325,	1254,	1182,	1171,	1076,	
972,	 959,	 813,	 764,	 721.	 MS	 (70	 eV,	m/z):	 504.7	 (M),	 486.4,	
462.4,	 436.4,	 408.3,	 388.2,	 312.2,	 285.1,	 158.1,	 232.2,	 205.2,	
1731,	147.0,	107.1,	80.1,	57.1.	
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Table	1.	Calculated	and	observed	band	maxima	and	intensities	of	compound	5.	
Excited	state	 Theoretical	λ,	nm	 Oscillator	strength	 Experimental	λ,	nm	
H‐3	→	L		 438	 0.0000	 Not	observed	
H‐3	→	L+1		
H‐3	→	L+4		
H‐3	→	L+5		
H‐3	→	L+6	
H‐3	→	L+7		
H‐2	→	L		 395	 1.8561		 400	
H‐2	→	L+4		
H‐1	→	L+1		
H	→L		
H‐1	→	L		 334	 0.1735	 327
H‐1	→	L+1		
H	→	L+1		
	
	
(1E,6E)‐1,7‐bis(4‐octyloxyphenyl)hepta‐1,6‐diene‐3,5‐dione	
(7):	 Color:	 Orange	 needles,	 recrystallized	 from	 ethanol.	 Yield:	
50	%.	M.p:	138‐140	oC.	1H	NMR	(200	MHz,	CDCl3,	δ	ppm):	0.88	
(6H	 ,	 t,	J	=	6.6	Hz,	CH3),	1.29	(8H,	m,	CH2),	1.55	(12H,	m,	CH2),	
1.77	 (4H,	 m,	 CH2),	 3.98	 (4H,	 t,	 J	 =	 6.2	 Hz,	 CH2),	 5.77	 (2H,	 s,	
vinylic	H	),	6.49	(2H,	d,	J	=	15.8	Hz,	CH=C),	6.90	(4H,	d,	J	=	8.8	
Hz,	Ar‐H),	7.25	(4H,	d,	J	=	8.0	Hz,	Ar‐H),	7.61	(2H,	d,	J	=	15.6	Hz,	
CH=C).	13C	NMR	(75	MHz,	CDCl3,	δ	ppm):	14.0,	22.6,	26.0,	29.1,	
29.2,	29.3,	 31.7,	68.1,	114.8,	121.6,	127.5,	129.7,	140.1,	160.9,	
183.3.	 IR	 (ATR,	 ν,	 cm‐1):	 3325,	 2921,	 2851,	 162,	 1599,	 1510,	
1466,	1324,	1276,	1258,	1171,	1137,	972,	870,	829,	784,	750,	
722.	 MS	 (70	 eV,	m/z):	 532.4	 (M),	 514.4,	 436.4,	 368.4,	 326.2,	
299.1,	259.1,	219.2,	189.1,	161.1,	133.1,	1.7.1,	83.1,	57.1.		
	
3.	Results	and	discussion	
	
The	synthetic	rout	 for	 the	studied	compounds	 is	shown	in	
Scheme	1.	
High	resolution	mass	spectroscopy	was	used	to	determine	
the	 molecular	 formulae	 of	 the	 synthesized	 compounds.	 In	 all	
cases	 the	difference	of	m/z	 values	between	 the	measured	and	
the	calculated	formula	less	than	5	parts	per	million.		
The	 most	 striking	 signal	 for	 the	 formation	 of	 the	
curcuminoids	 from	 their	 precursors	 is	 the	 ethylinic	 linkages,	
which	 were	 confirmed	 by	 1H	 NMR	 spectra	 evident	 by	 the	
presence	of	the	two	doublets	with	15‐16	Hz	coupling	constants.	
The	 1H	 NMR	 spectra	 of	 the	 synthesized	 compounds	 are	
characterized	 by	 four	 main	 signals.	 The	 alkyl/alkoxy	 protons	
chemical	 shifts	 are	 within	 the	 range	 2.60	 and	 3.90	 ppm.	 The	
signals	 that	appear	at	about	5.80	ppm	are	 in	consistence	with	
the	 chemical	 shifts	 of	 the	 enolic	 form	vinylic	protons	 that	 are	
characterizing	 the	 structures	 of	 β‐diketones	 in	 general.	 The	
presence	of	this	signal	and	the	absence	of	the	signal	of	the	CO‐
CH2‐CO	methylene	group	that	characterizes	the	diketo	form	in	
β‐diketones	 indicate	 that	 these	 compounds	 are	present	 in	 the	
enolic	 form	 mainly.	 This	 is	 in	 agreement	 with	 both	
experimental	 and	 theoretical	 results	 which	 found	 that	
curcumin	 presents	 mainly	 in	 the	 enolic	 form.	 The	 olefinic	
protons	 in	 the	 alkyl	 and	 alkoxy	 substituted	 compounds	 have	
their	 signals	 within	 the	 ranges	 6.49‐7.61	 and	 6.59‐764	 ppm	
characterize.	The	signals	of	the	aromatic	protons	appear	at	the	
range	 6.90‐7.49	 ppm	 and	 are	 self‐explanatory	 and	 could	 be	
simply	distinguished	from	those	of	the	olefinic	protons	by	their	
o‐coupling	with	 J‐coupling	 constants	within	 the	 range	 8‐9	Hz.	
13C	NMR	spectra	aid	further	support	to	the	enolic	character	of	
these	 compounds	 via	 two	 signals	 that	 appear	 at	 101	 and	 183	
ppm.	The	first	signal	 is	attributed	to	the	vinylic	carbon	(CO‐C‐
CO)	and	the	other	 is	attributed	to	the	carbonyl	group	that	 is	a	
part	of	 the	 intra‐hydrogen	bonded	chelated	central	ring	 in	the	
enolic	 form	 that	 are	 characterize	 the	 spectra	 of	 similar	 β‐
diketones.	The	IR	spectra	are	in	agreement	with	the	enolic	form	
of	 β‐diketones	 due	 to	 the	 large	 shift	 in	 the	 stretching	
frequencies	of	the	carbonyl	group	which	appears	in	general	at	
1620‐1626	 cm‐1	 due	 to	 the	 formation	 of	 the	 intra‐hydrogen	
bonded	chelated	central	ring	as	well	as	the	conjugation	with	the	
ethylenic	linkages.	
The	 electronic	 spectra	 of	 both	 the	 alkyl‐	 and	 alkoxy‐
substituted	 compounds	 are	 essentially	 identical	 and	
characterized	 by	 three	 bands	 accordingly	 the	 spectra	 of	 the	
compound	 5	 is	 discussed	 as	 representative	 example.	 The	
spectrum	 of	 this	 compound	 is	 characterized	 by	 strong	 and	
composite	 bands	 at	 218,	 246,	 326	 and	 400	 nm	 (in	 hexane)	
(Figure	1).	 According	 to	 their	 intensities	 these	maxima	 (in	 all	
cases	 ε	 is	 larger	 than	 104)	 are	 due	 to	 the	 electronic	 dipole	
allowed	 type	 π‐π*	 excitation	 of	 its	 extended	 π‐conjugation	
system.	For	the	longer	band	this	shift	is	10	nm.	Most	likely,	the	
weak,	 electronic	 dipole	 forbidden	 n‐π*	 bands	 are	 located	
somewhere	 under	 the	 main	 absorption	 bands.	 The	 relatively	
large	 wavelength	 bands	 of	 the	 spectra	 indicate	 that	 the	
compounds	exist	mainly	as	the	enolic	tautomer	in	the	solution.	
	
	
	
Figure	1.	The	UV‐VIS	spectrum	of	the	compound	3	in	ethanol	(blue	line	with	
the	band	at	390	nm)	and	 in	hexane	 (red	 line	with	 the	band	at	400	nm).	 In	
both	cases	the	concentration	is	2	x	10‐5	M.	
	
In	 order	 to	 discuss	 the	 origin	 of	 the	 spectra,	 singlet	
excited‐state	 calculations	 were	 done	 for	 compound	 4	 as	
representative	 for	 the	 rest	 since	 the	 spectra	 of	 the	 studied	
compounds	 (including	 both	 the	 methyl‐	 and	 methoxy‐
substituted)	are	essentially	identical.	A	theoretical	study	for	the	
origin	 of	 the	 electronic	 transitions	 in	 curcuminoids	 is	 not	
previously	done.	Calculations	were	performed	for	compound	5	
using	 Time	Dependent‐Self	 Consistent	 Field	 (TD‐SCF)	method	
on	 B3LYP/6‐31G(d,p)	 optimized	 structures.	 The	 predicted	
spectra	are	in	good	agreement	with	the	experimental	spectra	in	
hexane	especially	 for	 the	 longer	band	at	400	nm	which	 is	 the	
band	that	 is	responsible	 for	 the	 intense	yellow	colors	of	 these	
compounds.	 The	 electronic	 transitions	 are	 comprise	
components	 of	 HOMO	 to	 LUMO	 as	well	 other	 transitions	 like	
H‐1	to	L+1,	H	to	L+1,	H‐1	to	L,	H‐2	to	L,	H‐2	to	L+4	and	H‐3	to	
(L+4,	 L+5,	 L+6	 and	 L+7)	 as	 could	 be	 seen	 in	 Table	 1.	 The	
calculated	band	at	438	nm	(with	oscillator	strength	of	0.0000)	
may	 correspond	 to	 the	 n‐π*	 band	 in	 these	 compounds	 and	 is	
not	observable	due	to	its	location	under	the	much	more	intense	
π‐π*.	
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Figure	2.	 Representation	 of	 the	HOMO	 and	 LUMO	orbitals	 in	 the	A)	 alkyl‐	 and	 B)	 alkoxy‐substituted	 curcuminoids	 determined	 by	 B3LYP/6‐31G(d)	 level	 of	
theory.	
	
	
In	 order	 to	 account	 for	 both	 the	 extended	 spectra	 of	 the	
curcuminoids	 and	 their	 similarity	 in	 alkyl‐	 and	 alkoxy‐
substituted	 compounds	 the	 HOMO	 and	 the	 LUMO	 orbitals	 in	
these	compounds	were	calculated	at	the	B3LYP/6‐31G(d)	level	
of	 theory	 and	 are	 shown	 in	 Figure	 2.	 The	 orbitals	 are	 π‐
character	and	are	 extended	over	 the	whole	 structures	 in	both	
cases	explaining	the	extended	spectra	of	these	compounds.	On	
the	other	hand	the	orbitals	in	the	alkyl‐	and	alkoxy‐substituted	
compounds	 are	 essentially	 identical	 which	 may	 accounts	 for	
the	similarity	of	their	spectra.	
	
4.	Conclusion	
	
In	 this	 study	 alkyl‐	 and	 alkoxy‐	 substituted	 curcuminoids	
are	 prepared.	 The	 1H	 and	 13C	NMR,	 IR,	 and	UV‐VIS	 spectra	 of	
the	 studied	 compounds	 are	 essentially	 identical	 for	 the	 alkyl‐	
and	the	alkoxy‐derivatives	and	 indicate	 that	 these	compounds	
exist	mainly	in	the	enolic	form.	The	electronic	spectra	could	be	
theoretically	 reproduced	 to	 fairly	 match	 the	 experimental	
spectra	 using	 the	 B3LYP/6‐31G(d)	 level	 of	 theory.	 The	 close	
similarity	 of	 the	 electronic	 spectra	 of	 the	 two	 series	 of	
compounds	 is	 due	 to	 the	 close	 similarity	 of	 their	 frontier	
orbitals.	
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